Yoi O O, Seldin D C, Spragg J, Pinkus G S, Austen K F
Proc Natl Acad Sci U S A. 1979 Aug;76(8):3612-6. doi: 10.1073/pnas.76.8.3612.
A pancreatic endopeptidase localized to the beta-cells of the pancreas by immunohistochemical techniques has been purified to homogeneity by following its functional and antigenic characteristics as a glandular kallikrein (EC 3.4.21.8). The enzyme gave a single stained band on alkaline disc gel electrophoresis which corresponded in location with the kinin-generating activity eluted from a replicate gel, was of 54,000 molecular weight by gel filtration, was devoid of caseinolytic activity, elicited a monospecific antiserum in a rabbit, and gave a line of complete identity with a single constituent in pancreatic extract, crude urine, and purified urokallikrein when analyzed with monospecific antibody to urokallikrein. The pancreatic glandular kallikrein generated three cleavage products of increasing anodal mobility from bovine and porcine proinsulin, and the presence of pancreatic kininase or bovine carboxypeptidase B increased the quantity of these products. Although the conversion products did not correspond to diarginyl- and monoarginylinsulin, the product of intermediate mobility was also obtained when proinsulin was treated with a low concentration of trypsin in the presence of kininase. The most rapidly migrating product did correspond to desalanylinsulin in the reference standard. Kininase alone had no action on proinsulin, and aprotinin prevented cleavage by kallikrein alone or in combination with kininase. Although the chemical structure of the proinsulin cleavage products has not been established, human pancreatic kallikrein is considered a putative activator of proinsulin because of its location in the beta-cell, its preferential action on proinsulin and kininogen as compared to azocasein, and its capacity to generate insulin intermediate products that are further modified by human pancreatic kininase or bovine carboxypeptidase B.
通过免疫组织化学技术定位到胰腺β细胞的一种胰腺内肽酶,已根据其作为腺体激肽释放酶(EC 3.4.21.8)的功能和抗原特性纯化至同质。该酶在碱性圆盘凝胶电泳上呈现单一染色带,其位置与从重复凝胶上洗脱的激肽生成活性相对应,通过凝胶过滤法测得分子量为54,000,无酪蛋白溶解活性,在兔体内引发单特异性抗血清,并且在用抗尿激酶单特异性抗体分析时,与胰腺提取物、粗尿液和纯化的尿激酶中的单一成分呈现完全一致的条带。胰腺腺体激肽释放酶从牛和猪胰岛素原产生了三种向阳极迁移率增加的裂解产物,胰腺激肽酶或牛羧肽酶B的存在增加了这些产物的量。尽管转化产物与双精氨酸胰岛素和单精氨酸胰岛素不对应,但当胰岛素原在激肽酶存在下用低浓度胰蛋白酶处理时,也获得了迁移率中等的产物。迁移最快的产物确实与参考标准中的脱丙氨酰胰岛素相对应。单独的激肽酶对胰岛素原无作用,抑肽酶可阻止激肽释放酶单独或与激肽酶联合时的裂解。尽管胰岛素原裂解产物的化学结构尚未确定,但人胰腺激肽释放酶因其位于β细胞中,与偶氮酪蛋白相比对胰岛素原和激肽原具有优先作用,以及其产生可被人胰腺激肽酶或牛羧肽酶B进一步修饰的胰岛素中间产物的能力,而被认为是胰岛素原的一种假定激活剂。